Targeted Genome Editing Using DNA-Free RNA-Guided Cas9 Ribonucleoprotein for CHO Cell Engineering

Author(s):  
Jongoh Shin ◽  
Namil Lee ◽  
Suhyung Cho ◽  
Byung-Kwan Cho
2020 ◽  
Vol 9 (7) ◽  
pp. 1572-1580
Author(s):  
Youngsik Lee ◽  
Jin Myeong Kwak ◽  
Jae Seong Lee
Keyword(s):  

2020 ◽  
Vol 219 (7) ◽  
Author(s):  
Danming Tang ◽  
Wendy Sandoval ◽  
Cynthia Lam ◽  
Benjamin Haley ◽  
Peter Liu ◽  
...  

Accumulation of unfolded antibody chains in the ER triggers ER stress that may lead to reduced productivity in therapeutic antibody manufacturing processes. We identified UBR4 and UBR5 as ubiquitin E3 ligases involved in HC ER-associated degradation. Knockdown of UBR4 and UBR5 resulted in intracellular accumulation, enhanced secretion, and reduced ubiquitination of HC. In concert with these E3 ligases, PDIA3 was shown to cleave ubiquitinated HC molecules to accelerate HC dislocation. Interestingly, UBR5, and to a lesser degree UBR4, were down-regulated as cellular demand for antibody expression increased in CHO cells during the production phase, or in plasma B cells. Reducing UBR4/UBR5 expression before the production phase increased antibody productivity in CHO cells, possibly by redirecting antibody molecules from degradation to secretion. Altogether we have characterized a novel proteolysis/proteasome-dependent pathway involved in degradation of unfolded antibody HC. Proteins characterized in this pathway may be novel targets for CHO cell engineering.


Author(s):  
Tatiana Dovgan ◽  
Vahid Golghalyani ◽  
Fabio Zurlo ◽  
Diane Hatton ◽  
Viv Lindo ◽  
...  

2014 ◽  
Vol 21 ◽  
pp. 91-102 ◽  
Author(s):  
Valérie Le Fourn ◽  
Pierre-Alain Girod ◽  
Montse Buceta ◽  
Alexandre Regamey ◽  
Nicolas Mermod

2015 ◽  
Vol 33 (8) ◽  
pp. 1878-1896 ◽  
Author(s):  
Simon Fischer ◽  
René Handrick ◽  
Kerstin Otte

2021 ◽  
Author(s):  
Dominika Jedrzejczyk ◽  
Line Dahl Poulsen ◽  
Marina Mohr ◽  
Nkerorema Djodji Damas ◽  
Sanne Schoffelen ◽  
...  

Abstract CRISPR-Cas12a systems are becoming an attractive genome editing tool for cell engineering due to their broader editing capabilities compared to CRISPR-Cas9 counterparts. As opposed to Cas9, the Cas12a endonucleases are characterized by a lack of trans-activating crRNA (tracrRNA), which reduces the complexity of the editing system and simultaneously makes CRISPR RNA (crRNA) engineering a promising approach toward further improving and modulating editing activity of the CRISPR-Cas12a systems. Here, we design and validate eleven types of structurally engineered Cas12a crRNAs targeting various immunologically relevant loci in-vitro and in-cellulo. We show that all our structural modifications in the loop region, ranging from engineered breaks (STAR-crRNAs) to large gaps (Gap-crRNAs), as well as nucleotide substitutions, enable gene-cutting in the presence of various Cas12a nucleases. Moreover, we observe similar insertion rates of short HDR templates using the engineered crRNAs compared to the wild-type crRNAs, further demonstrating that the introduced modifications in the loop region lead to comparable genome editing efficiencies. In conclusion, we show for the first time that Cas12a nucleases can broadly utilize structurally engineered crRNAs with breaks or gaps in the otherwise highly-conserved loop region, which could further facilitate a wide range of genome editing applications.


Sign in / Sign up

Export Citation Format

Share Document